Health technology assessment (HTA) is a solid tool for helping make decisions on health care costs and innovation in the current landscape, according to Institute for Clinical and Economic Review President Steve Pearson.
” … (HTA is) supposed to help foster the right kinds of decisions,” Pearson said in an interview with the American Journal of Managed Care. “We have to decide how we are going to balance the incentives for innovation with the affordability for the health care system … .”
Pearson said managing the latter balance is a problem “every health system around the world” is working to address.
“What HTA does is it tries to make sure that it takes an objective and transparent approach to judging the evidence, so that the discussions about how we innovated and how we price and how we pay for services can be held on the basis of fairly evaluated evidence,” Pearson said. “It helps raise the bar and make sure that everybody is playing on the same level playing field.”